AMGEN INC is 182.3x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($182.28 B vs $1.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGEM | AMGN |
|---|---|---|
| Market cap | $1.00 B | $182.28 B |
| US-listed rank | #2637 | #80 |
| Revenue (latest FY) | $0.00 | $36.75B |
| Net income (latest FY) | -$219.88M | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 23.6 |
| SEC filings | 435 | 1,011 |
AMGEN INC is 182.3x more valuable than Cullinan Therapeutics, Inc. by market capitalization ($182.28 B vs $1.00 B).
In their latest fiscal years, Cullinan Therapeutics, Inc. reported $0.00 in revenue while AMGEN INC reported $36.75B.
Full pages: Cullinan Therapeutics, Inc. and AMGEN INC, or browse the full rankings.